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Background: Intravenous leiomyomatosis (IVL) is a rare tumor that is histologically benign but biologically malignant.
Less than 200 cases of IVL have been reported, most of them were individual reports.
Methods: Six patients with IVL involving the inferior vena cava were analyzed.
Results: Three patients received one-stage operations and two received two-stage operations. All operations were
successful. No perioperative death or other complications were observed. Primary tumors and intravenous tumorous
emboli were completely resected from four patients. Residual tumor remained in one patient who had serious adhesions
due to multiple previous surgeries; however, with antiestrogen therapy, the residual tumor significantly regressed. All
patients had tumor relapse after the operation.
Conclusions: IVL should be given more attention by vascular surgeons, although it is extremely rare. Many therapeutic
methods are available for uterine leiomyomatosis involving inferior vena cava, among which operation is the best choice.
(J Vasc Surg 2009;50:897-902.)Intravenous leiomyomatosis (IVL) is a rare, histologi-
cally benign tumor. By the end of 2006,200 cases of IVL
had been reported, of which 113 involved the heart. Most
were individual case reports.1,2 We retrospectively studied
six patients with IVL who were admitted to Peking Union
Medical College Hospital between July 2000 and February
2008. Three were treated with one-stage resections and
two with two-staged surgical procedures. We analyzed the
operation indications and the operative options of the
patients.
METHODS
Patients. We evaluated six women who were average
age of 40.5  9.1 years. The major clinical feature was
pelvic masses. In addition, one patient had an increase in
menstrual blood, one had chest tightness and palpitation,
and another had ascites and lower extremity edema. All
patients had been previously diagnosed with uterine
leiomyoma pathologically. The diagnosis of uterine leiomy-
oma before the current IVL diagnosis was at 27, 21, 16,
and 2 months, respectively in four of the patients. Two
patients were at “0 month,” which means that they were
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the same time.
The imaging examinations, including computed to-
mography (CT), magnetic resonance imaging (MRI) and
B-ultrasound scanning, showed pelvic masses in all pa-
tients, with inferior vena cava and right atrium involvement
in four, and pelvic venous plexus involvement in one. All six
patients were confirmed to have no pulmonary embolism.
Before the current hospital admission, two patients had
two previous surgeries and one patient had four proce-
dures. Three patients had hysterectomy, one patient under-
went thrombectomy from the inferior vena cava and iliac
vein, and one had ovarian teratoma resection (Table I).
Operations. Three patients had one-stage resections,
all of which were pelvic tumor resections, together with
thrombectomy from the inferior vena cava and iliac vein.
Two patients had two-stage operations. One patient had an
abdominal hysterectomy, double annex removal, and tu-
mor thrombus resection from the inferior vena cava and
iliac vein, and then thrombectomy from the right atrium
and the inferior vena cava with extracorporeal circulation
under the appropriate conditions. The other patient first
had thrombectomy from the right atrium and the inferior
vena cava under cardiopulmonary bypass (CPB), and then
the uterine and double annex resection (Table II; Fig 1).
One patient did not have surgical intervention due to
serious heart and lung dysfunction. All patients’ pathology
was IVL (Table II).
RESULTS
All five operations were performed successfully, with-
out perioperative death or complications. Four patients
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tumorous vein thrombus resection. One patient had resid-
ual tumor because of repeated previous surgeries and seri-
ous pelvic adhesions, but the tumor significantly reduced
after antiestrogen treatment for 2 years until the last
follow-up at the end of 2008.
The amount of bleeding for the three one-stage oper-
ations was comparably large, at 8000, 5000, and 4000 mL.
The amount of bleeding for two two-stage procedures was
less, at 3000 and 2000 mL.
Postoperatively, all patients were appropriately admin-
istered low-molecular-weight heparin or ordinary heparin
treatment during the periprocedural period according to
the body weight and bleeding after the operation. Patients
were maintained on regular anticoagulant warfarin treat-
ment for 9 to 12 months to achieve an international nor-
malized ratio of 2 to 3.
Recurrence after the operation. Three patients had
postoperative recurrence integrated with case history and
previous operation history. The longest recurrence oc-
curred 43 months after the first operation. The median of
recurrence was 14 months. After the operation in our
Table I. The common conditions of the six patients
Patient Age, y Main symptoms
1 48 Menstruation increase
Recurrence of pelvic mass post-op
2 41 Intermittently flustered, chest tightness
Mass in the right pelvis
3 49 Edema of both lower legs, with increasin
abdominal distention
4 24 Solid occupying mass in IVC after
operation of intravascular smooth
muscle
5 43 Intravascular leiomyomatosis post-op
6 38 Pelvic mass after uterine fibroids operati
CDU, Color Doppler ultrasound; IVC, inferior vena cava; RA, right atriumhospital, except for one patient with residual tumor becauseof repeated surgery and serious pelvic adhesions, the other
four patients were followed up, without recurrence.
Follow-up. All six women have been carefully fol-
lowed up until the end of 2008. The average follow-up
period was 58.5  26.8 months (range, 30-100 months).
DISCUSSION
IVL is a rare, histologically benign tumor, related to
uterine stromal tumors, characterized by smooth cells
growth along the uterus or extrauterine venous system, or
both.3,4 In addition to veins, IVL can also involve lym-
phatic vessels and is then known as intravascular leiomyo-
matosis. Until now, 200 cases of this disease have been
reported, and all have been women because of the relation
with uterine stromal tumors. Pathologic changes beyond
the uterus occur in 30% to 80%,5 among which heart
involvement occurs in 10% to 30%.6
There are two main hypotheses about the generation
of leiomyomatosis inside the vessels. Knauer7 suggests
that the tumor originates from smooth muscle of the
vessel wall, whereas Sitzenfry8 proposes the uterine
leiomyoma as the origin with subsequent invasion of
Gyn exam
16-18 week- sized uterus; hard mass out of left part
Uterus was very close to the pelvic mass, large as size of 18-
wk pregnancy
Pelvic nodular cluster mass next to double uterus annex;
painful to touch pain, 4-5-cm mass on the right
Middle and lower abdomen 15  5 cm mass, 2-finger
location under hilum, anus diagnose: 4-week-pregnant
uterus, soft quality
20-cm solid mass can be touch in the right pelvis, without
moving, very close to the pelvic wall
7  6  6-cm hard, solid mass at the upper left cervical, fixedg
onvenous channels.
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ical behavior is malignant. IVL can grow along the vein
as well as partially adhesive; rarely, IVL grows infiltra-
tively.9,10 Included among the main characteristics of IVL
under the microscope are tumor that is composed of
smooth muscle cells with various degrees of proliferation;
tumor that invades into the blood vessels within myome-
trium; and most cases show benign cytology, with none or
a small amount of nuclear fission (2 per high power field).
Tumor recurrence is mainly based on pathology.
There are several possible pathways for this disease to
penetrate into the inferior vena cava or heart, one of which
is that it first invades the veins within the uterus and ovaries,
then goes into the iliac vein, and finally into the inferior
vena cava or heart.1 Invasion of pelvic veins and vena cava
by leiomyoma and its possible extension to right cardiac
chambers may cause a variable spectrum of symptoms,
ranging from sudden death, cardiac tamponade, dyspnea,
tachycardia, and arrhythmias, to abdominal pelvic pressure
or abnormal bleeding, edema of the inferior limbs, or even
Table I. Continued.
B-Ultrasound H
Lumen continuity, solid echoes in the IVC,





Myometrium multiple solid occupying masses,
solid mass in right uterus, right atrium, and
the IVC. No specific branches of vein filling
defect
Solid in mass in
continues to
10.9-  7.3-cm, mid-level echo, disparted-
fronds, IVC and iliac vein thrombosis,
Budd-Chiari syndrome; larger liver, pelvic
solid mass; 10.9-  7.3-cm, mid-echo,
disparted-frond-like




10.6-  9.9-  8.4-cm right iliac vein to the
IVC, embolization, the lower echo 10.6- 




Huge solid pelvic mass, uneven echo inside,
with the surrounding tissue and th IVC
border unclear, broadening of IVC, grid-
like echo, consider recurrence; right pelvis
widened; vena cava universal expansion,
network-like changes below renal vein
lumen levelBudd-Chiari syndrome.11One of the following circumstances should be taken
into account for the possibility of the diagnosis of IVL:
1. Multiple uterine fibroids with pathologic changes in-
volving parauterine tissues and annex, especially when a
worm-like or cable-like invasive tumors are found in the
blood vessels under the microscope.
2. Patients have a history of uterine fibroids or uterine surgery,
accompaniedbyoneof the following: the rightatriumtumor,
right heart dysfunction, inferior vena cava obstruction syn-
drome, Budd-Chiari syndrome, or deep vein thrombosis.
CT, MRI, and CT vein (CTV) reconstructions are very
helpful for the diagnosis of IVL.
Surgical resection is the best choice for the treatment of IVL.
Resection should include the uterus-parauterine tissues, ovaries,
Fallopian tubes, and intravenous tumor. Because the tumor is
estrogen-dependent, ovariectomy should be performed and an-
tiestrogen therapy should be prescribed. Complete removal of
the tumor is the key to prevent the recurrence.12
Since 1982 when Ariza first performed a successful
DU CT
m, widened IVC;
he right of the
thout adhesion
Multiple uterine fibroids, not the exception
of malignant. Abdominal tumor, with




Obviously uneven enhanced video in the
soft tissue of uterine right wall and
cervix, no filling defect in right atrium,




Liver change, consider the congestion
caused by the liver, larger spleen,
malignant change possible. Right iliac
vein, IVC, and RA embolism, not the
exception of tumor thrombus
lume, increased
ity, oppression
Larger uterine, density of inequality,
oppress to the ureter, with the right
renal pelvis and ureter expansion, uterine
muscle tumors possible, abnormal
density shape in the right iliac vein and
the IVC, consistent with tumor
thrombus
Huge pelvic occupying mass, subfronds,
strengthen and uneven, rich of vascular
shape (with intravascular
leiomyomatosis), widened IVC, not clear
lower end trunk shape, collateral branch
circulation in the abdominal wall, large
retroperitoneal part, occlusion in the left
iliac vein
Slid pelvic mass, 7  9.3 cm real mass











qualstaged IVL resection, most researchers have adopted
involved the uterine vein.
ER, Estrogen receptor; IVC, inferior vena cava; IVL, intravenous leiomyomatosis
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abdominal-pelvic surgery and chest surgery.13 Recently,
a successful one-stage tumor resection with low temper-
ature and CPB was reported.14 Katsumata et al15 re-
ported that the atrial tumor was successfully removed
with a single-stage approach through a sternal laparot-
omy and total circulatory arrest using CPB. The intra-
vascular lesion was 48 cm long and 10 cm wide.15
We included cardiac, vascular, and obstetric and gyne-
cologic surgeries in the one-stage operation. We first re-
sected the uterus, ovaries, and Fallopian tubes, with simul-
taneous iliac vein and inferior vena cava control. We then
performed a sternotomy and pericardiotomy and directly
opened the right atrium and the inferior vena cava to
remove the tumor entirely, using CPB.
We believe that one-stage surgery with CPB can clarify
the surgical field, completely remove the tumor, and reduce
thrombosis events during the operation. One-stage opera-
tions also have many shortcomings, however, including
longer operation time, increased trauma, more bleeding,
and more postoperative complications.11,16 In our group,
the three cases of one-stage surgery were successful, but the
blood loss was relatively more (Fig 2).
The staged surgery includes an upper renal vein stage
and lower renal vein stage, with an interval between the
two. The interval time can be decided according to the
patient’s recovery status after the first surgery. For slow-
growth tumor, some authors have waited up to 6 weeks to
undertake the second stage.16
In the first patient who underwent a two-stage opera-
tion, the first stage was the abdominal hysterectomy and
Postoperative pathology
r RA and the IVC consistent with intravascular
leiomyomatosis, PR, ER–, vimentin, SMA,
desmin, Ki-67, 1%
Uterine intravascular smooth leiomyomatosis, (left
uterine arteriovenous and right ovary arteriovenous);
tumor thrombus inside
a Right heart, the vena cava intravascular leiomyomatosis:
active growth, SMA, PR, ER, desmin,
vimentin
n Uterine IVL; tumor extension along the bilateral sides.
Coil formation of nodules at the right side of uterus
(right parauterine vascular), a little leiomyoma
organizations
IVC inside consistent with IVL; right annex, ovarian
cortical atrophy, visible thick-walled blood vessels in
medulla, SMA, desmin, CD34, CD10–
Pelvic, uterine cavity low antrum and active growth
leiomyomatosis at the back wall of uterine. CD34
(vascular ), CD117–, desmin, ER–, PR, Ki-
67 (a few scattered )
Pelvic, retroperitoneal intravascular leiomyomatosis
(cell type), active cell growth, PR, ER–
; PR, progesterone receptor; RA, right atrium; SMA, smooth muscle actin.Fig 1. A, Gross specimen of an intravenous leiomyomatosis
(IVL) resected from the involved inferior vena cava. B, Gross
specimen of an IVL resected from uterine smooth muscle thatTable II. The options and pathology of the operations
Case No. Postoperative situation
1 Cryogenic CPB, iliac vein, the vena cava, the RA tumo
thrombus extraction
Hysterectomy, double-annex pelvic vascular tumor
thrombus extraction
2 Cryogenic CPB removal of tumor thrombus from ven
cava-right atrium
Hysterectomy, double annex with bilateral ovarian vei
high level ligation, the release of adhesion
3 Pelvic exploration, hysterectomy  double annex
resection with the IVC, vascular smooth muscle
tumor resection
4 Hysterectomy  double resection of the annex;
removal and repair of posterior wall of the bladder,
partial resection of the right ureter, plant into the
bladder; IVC tumor thrombectomy and repair
5 Residual cervical, left annex and pelvic tumor resection
of recurrence, pelvic vein tumor thrombus partly
resectedthe tumor resection via the vena cava. Because the tumor
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the atrium during the first stage of operation. In the second
stage, we removed the tumor via heart surgery. The lesson
of this case was that when tumor grew into the atrium,
blindly pulling the tumor from inferior vena cava was not
advised because of high risk of pulmonary embolism. On
the other hand, simply pulling the tumor out of the right
atrium was not feasible. The attachment point of the tumor
was in the pelvic veins, and attempted removal from the
thoracic approach would result in either failure of complete
retrieval of the tumor or tearing of the vein at the point of
attachment.1,15 Virzì et al17 used a double-staged surgical
strategy of cardiovascular and gynecologic operations for
tumor resection to expose the patient to a lower postoper-
ative bleeding risk.
Because of the lessons we learned from the operations
in the previous patients, for the second two-stage opera-
tion, we first removed the tumor via the atrium and the
upper inferior vena cava under CPB, then we completely
removed the tumor from the infrarenal vena cava. In the
second stage, control of the vena cava was established in the
infrarenal region, adequate venous return was ensured, and
the risk of incomplete resection and embolization was
lowered.18
Two-stage surgery is suitable for patients in poor con-
Fig 2. Sketch map shows one-stage surgery using cardiopulmo-
nary bypass.dition who cannot tolerate a one-stage resection. Althoughstaging the operation can avoid the shortcomings of a
one-stage procedure, it may pose a threat due to possible
tumor emboli.16 A temporary filter is an optional method
in the first stage of surgery, then the tumor resection would
be performed through the infrarenal vena cava after an
interval; however, this technique is not recommended rou-
tinely.
Although the IVL grew along blood vessels, we found
it could also be loosely attached to the vessel wall without
significant thrombosis, and the removal of intracaval and
intracardiac leiomyomatosis could be performed without
any difficulty. When the tumor had a diameter that was
narrower than that of inferior vena cava, the tumor could be
removed directly through the iliac vein under the protec-
tion of proximal inferior vena cava.
As reported previously, estrogen and progesterone re-
ceptors were found in the vein and the cytoplasm of meta-
static tumors, so antiestrogen therapy seems to be justified
in patients who have postoperative residual tumor cells or
incompletely resected tumor. Up to now, conventional
application of tamoxifen treatment has been used.4,14 In
our group, immunohistochemistry confirmed one patient
was estrogen receptor-positive, and four were progesterone
receptor-positive. One patient received antiestrogen ther-
apy after the operation.
Ahmed et al19 reported an IVL recurrence rate of about
30%, so follow-up is very important. Usually, it should be
done at 3, 6, and 12 months after the operation and
annually thereafter. Follow-up mainly includes abdominal
and pelvic ultrasound imaging, inferior vena cava and iliac
vein color Doppler ultrasound imaging, and CTV.
We believe that IVL is not a single disease entity; rather,
it is actually a group of diseases with different clinical
manifestations. Although IVL is an extremely rare tumor,
vascular surgeons should pay attention to any patients
presenting with venous thrombosis and uterine leiomyoma.
Correct diagnosis and proper surgeries are critical for the
treatment of IVL.
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